ID

15837

Descrizione

Celecoxib (Celebrex) Versus Placebo in Men With Recurrent Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00136487

collegamento

https://clinicaltrials.gov/show/NCT00136487

Keywords

versioni (1)
  1. 15/06/16 15/06/16 -
Caricato su

15 giugno 2016

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Prostate Cancer NCT00136487

Inglese

Eligibility Prostate Cancer NCT00136487

1 moduli  
Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
diagnosis of prostate cancer
Descrizione

prostate cancer

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0600139
progression following prostatectomy or radiation to the prostate, defined as 3 psa rises, with each psa determination at least 4 weeks apart
Descrizione

disease progression

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0242656
UMLS CUI [2]
C0138741
UMLS CUI [3,1]
C0033573
UMLS CUI [3,2]
C1522449
psa greater than or equal to 1.0 for men who had a prostatectomy
Descrizione

psa

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0138741
psa greater than or equal to 3.0 for men who were treated with primary radiation therapy (external beam and/or brachytherapy)
Descrizione

psa radiation therapy

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0138741
UMLS CUI [1,2]
C1522449
psa doubling time between 6 and 24 months
Descrizione

psa doubling time

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0138741
UMLS CUI [1,2]
C1521828
UMLS CUI [1,3]
C1518823
participants must be either fully active and asymptomatic or symptomatic but fully ambulatory
Descrizione

fully active and asymptomatic

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0205177
UMLS CUI [2]
C0231221
adequate bone marrow function, kidney function and liver function as evidenced by laboratory results
Descrizione

bone marrow function

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0005953
UMLS CUI [2]
C0232804
UMLS CUI [3]
C0232741
Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
evidence of metastatic disease
Descrizione

metastatic disease

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0027627
prior hormonal therapy for recurrent prostate cancer
Descrizione

hormonal therapy

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0279025
UMLS CUI [1,2]
C0278838
prior chemotherapy for recurrent or metastatic prostate cancer
Descrizione

chemotherapy

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0392920
radiation therapy within 6 months
Descrizione

radiation therapy

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1522449
patients allergic to non-steroidal anti-inflammatory drugs (nsaids), salicylates or sulfonamide-type medications who experience asthma or urticaria (hives) after taking aspirin or other nsaids
Descrizione

allergy to nsaids

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0003211
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0036077
patients taking a dose of aspirin greater than or equal to 325 mg a day within 4 weeks of study entry
Descrizione

aspirin

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0004057
UMLS CUI [1,2]
C0178602
patients taking selective cox-2 inhibitors or any nsaids other than aspirin within 8 weeks of study entry
Descrizione

selective cox-2 inhibitors

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1257954
patients taking fluconazole, lithium or warfarin
Descrizione

fluconazole lithium or warfarin

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0016277
UMLS CUI [2]
C0023870
UMLS CUI [3]
C0043031
history of gastrointestinal or abdominal ulceration or any history of significant gastrointestinal bleeding in the past 12 months
Descrizione

ulceration or bleeding

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0237938
UMLS CUI [2]
C0017181
any history of myocardial infarction in the past 12 months
Descrizione

myocardial infarction

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0027051
any uncontrolled, serious medical or psychiatric illness
Descrizione

serious medical or psychiatric illness

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0009488
Ritorna all'inizio della pagina

Similar models

Eligibility Prostate Cancer NCT00136487

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
prostate cancer
Item
diagnosis of prostate cancer
boolean
C0600139 (UMLS CUI [1])
disease progression
Item
progression following prostatectomy or radiation to the prostate, defined as 3 psa rises, with each psa determination at least 4 weeks apart
boolean
C0242656 (UMLS CUI [1])
C0138741 (UMLS CUI [2])
C0033573 (UMLS CUI [3,1])
C1522449 (UMLS CUI [3,2])
psa
Item
psa greater than or equal to 1.0 for men who had a prostatectomy
boolean
C0138741 (UMLS CUI [1])
psa radiation therapy
Item
psa greater than or equal to 3.0 for men who were treated with primary radiation therapy (external beam and/or brachytherapy)
boolean
C0138741 (UMLS CUI [1,1])
C1522449 (UMLS CUI [1,2])
psa doubling time
Item
psa doubling time between 6 and 24 months
boolean
C0138741 (UMLS CUI [1,1])
C1521828 (UMLS CUI [1,2])
C1518823 (UMLS CUI [1,3])
fully active and asymptomatic
Item
participants must be either fully active and asymptomatic or symptomatic but fully ambulatory
boolean
C0205177 (UMLS CUI [1])
C0231221 (UMLS CUI [2])
bone marrow function
Item
adequate bone marrow function, kidney function and liver function as evidenced by laboratory results
boolean
C0005953 (UMLS CUI [1])
C0232804 (UMLS CUI [2])
C0232741 (UMLS CUI [3])
Item Group
C0680251 (UMLS CUI)
metastatic disease
Item
evidence of metastatic disease
boolean
C0027627 (UMLS CUI [1])
hormonal therapy
Item
prior hormonal therapy for recurrent prostate cancer
boolean
C0279025 (UMLS CUI [1,1])
C0278838 (UMLS CUI [1,2])
chemotherapy
Item
prior chemotherapy for recurrent or metastatic prostate cancer
boolean
C0392920 (UMLS CUI [1])
radiation therapy
Item
radiation therapy within 6 months
boolean
C1522449 (UMLS CUI [1])
allergy to nsaids
Item
patients allergic to non-steroidal anti-inflammatory drugs (nsaids), salicylates or sulfonamide-type medications who experience asthma or urticaria (hives) after taking aspirin or other nsaids
boolean
C0020517 (UMLS CUI [1,1])
C0003211 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0036077 (UMLS CUI [2,2])
aspirin
Item
patients taking a dose of aspirin greater than or equal to 325 mg a day within 4 weeks of study entry
boolean
C0004057 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
selective cox-2 inhibitors
Item
patients taking selective cox-2 inhibitors or any nsaids other than aspirin within 8 weeks of study entry
boolean
C1257954 (UMLS CUI [1])
fluconazole lithium or warfarin
Item
patients taking fluconazole, lithium or warfarin
boolean
C0016277 (UMLS CUI [1])
C0023870 (UMLS CUI [2])
C0043031 (UMLS CUI [3])
ulceration or bleeding
Item
history of gastrointestinal or abdominal ulceration or any history of significant gastrointestinal bleeding in the past 12 months
boolean
C0237938 (UMLS CUI [1])
C0017181 (UMLS CUI [2])
myocardial infarction
Item
any history of myocardial infarction in the past 12 months
boolean
C0027051 (UMLS CUI [1])
serious medical or psychiatric illness
Item
any uncontrolled, serious medical or psychiatric illness
boolean
C0009488 (UMLS CUI [1])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial